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Abstract
Human adenoviruses (HAdVs) are nonenveloped proteinaceous particles containing a lin-
ear double-stranded DNA genome. HAdVs cause a spectrumof pathologies in all popula-
tions regardless of health standards. Following repeat exposure to multiple HAdV types, we
develop robust and long-lived humoral and cellular immune responses that provide life-long
protection from de novo infections and persistent HAdV. How HAdVs, anti-HAdV antibodies
and antigen presenting cells (APCs) interact to influence infection is still incompletely under-
stood. In our study, we used physical, pharmacological, biochemical, fluorescence and
electronmicroscopy, molecular and cell biology approaches to dissect the impact of
immune-complexed HAdV (IC-HAdV) on humanmonocyte-derived dendritic cells
(MoDCs).We show that IC-HAdV generate stabilized complexes of ~200 nm that are effi-
ciently internalized by, and aggregate in, MoDCs. By comparing IC-HAdV, IC-empty capsid,
IC-Ad2ts1 (a HAdV-C2 impaired in endosomal escape due to a mutation that impacts prote-
ase encapsidation) and IC-AdL40Q (a HAdV-C5 impaired in endosomal escape due to a
mutation in protein VI), we demonstrate that protein VI-dependent endosomal escape is
required for the HAdV genome to engage the DNA pattern recognition receptor AIM2
(absent in melanoma 2). AIM2 engagement induces pyroptotic MoDC death via ASC (apo-
ptosis-associated speck protein containing a caspase activation/recruitment domain)
aggregation, inflammasome formation, caspase 1 activation, and IL-1β and gasderminD
(GSDMD) cleavage. Our study provides mechanistic insight into how humoral immunity ini-
tiates an innate immune response to HAdV-C5 in human professional APCs.
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Author Summary
While numerous studies have addressed the response to primary virus infections, we
know relatively little about the interplay between recurrent and/or persistent infections
and the memory humoral immune response on professional antigen-presenting cells.
Immune complexed-adenoviruses are present in patients suffering from adenoviremia. In
addition to the impact of HAdV infections on healthy and immune suppressed hosts,
humoral immunity hampers the use of human adenovirus vectors during gene transfer.
Our study shows that anti-adenovirus humoral immunity engages an innate immune
response to cause pyroptosis of antigen-presenting cells. The downstream effects of this
cells death is unknown and may impact the stimulation and differentiation of T cells into
an inflammatory phenotype that may be associated with the complications during adeno-
virus disease and adenovirus vector use. Our study generates insight into how humoral
immunity shapes the response to adenoviruses in healthy and immune-compromised
individuals, during human adenovirus-basedvaccine use, and during antibody therapy.
Introduction
Adenoviruses (AdVs) have a 28–42 kilobase pair double-strandedDNA genome encapsidated
in a nonenveloped proteinaceous icosahedral shell. In immune-competent individuals, human
AdVs (HAdVs) (of which there are approximately 70 types) cause self-limiting respiratory,
ocular and gastro-intestinal tract infections. After repeated encounters, we typically develop
multifaceted long-lived memory immune responses [1–3] that efficiently blunt HAdV-induced
disease. In spite of the robust cross-reacting cellular and humoral immune responses, HAdVs
can establish subclinical persistent infections that last for years, if not decades [4,5]. Not sur-
prisingly, HAdV type-specific humoral immunity before hematopoietic stem cell transplanta-
tion is predictive of escape of the same type during immune suppression [6].
Given the ubiquitous humoral immunity against HAdV, it is not surprising that immune-
complexed (IC) HAdVs (IC-HAdVs) are detected in some patients with HAdV infections [7–
9]. IC-viruses can form during prolonged viremia, secondary infections, in primary infection
when a cross-reactive humoral response exists, and antibody (Ab)-based antiviral immuno-
therapies. In B-cell competent/T-cell compromised patients, the loss of control of persistent
HAdV infectionmight trigger, or exacerbate, graft-versus host disease [10–12]. While IC-anti-
gens are efficient stimulators of dendritic cell (DC)maturation [13], most studies have used
prototype antigens that have little impact on processing of the immune complex. How
IC-HAdVs are processed and affect DC function are unknown.
DCs are equipped with a broad set of pattern recognition receptors (PRR) to detect patho-
gen-associatedmolecular patterns (PAMP) at the plasma membrane, in vesicles, or in the cyto-
sol. Foreign DNA is a PAMP that can be detected in endolysosomes by Toll-like receptor 9
(TLR9) and in the cytosol by absent in melanoma 2 (AIM2) [14]. Nucleic acid sensing by TLRs
stimulates a broad set of signaling pathways, notably, the NF-κB, AP-1, interferon-regulating
factors pathway and/or inflammasome formation [15]. The inflammasome is a multiprotein
platform formed in the cytosol consisting of a PRR, ASC (apoptosis-associated speck protein
containing a caspase activation/recruitment domain), and caspases [16]. Upon induction,
inflammasome sensors AIM2 or nucleotide-binding domain and leucine-rich repeat contain-
ing protein 3 (NLRP3) initiate aggregation of ASC that in turn prompts recruitment [17] and
proximity-induced caspase 1 auto-activation [18], and pro-1β and gasderminD (GSDMD)
cleavage [19]. Stimuli that induce inflammasome activation can be as diverse as cytosolicDNA
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[18], extracellular adenosine triphosphate [20], plasma membrane rupture [21], and/or lyso-
somal rupture releasing cathepsin B into the cytosol [22].
Inflammasome-mediated effects play contrasting roles in vaccination [23,24], during infec-
tion in immune-compromised hosts [25], and auto-inflammatory disease [26]. Of note, inflam-
masome activation can result in pyroptosis [27], an inflammatory form of cell death
characterized by caspase 1 activation and rapid loss of plasma membrane integrity due to
GSDMD cleavage [19]. In PAM3CSK4-primed THP-1 cells, super-infectionwith HAdV-C5
causes endosomal lysis and cathepsin B release, which is accompanied with mitochondrial
stress, ROS formation, NLRP3 inflammasomes, and IL-1βmaturation and secretion [28–30].
Interestingly, IL-1β secretion is higher in primed THP-1 cells when challenged with HAdV-C5
pre-incubated with human serum [30,31], but the underlyingmechanism is unknown. In addi-
tion, for three decades vectors derived from human and nonhuman AdV types have been
developed as candidates for infectious disease vaccination, and pre-clinical results have often
been impressive. However, use in humans has not been without concerns [32,33]: two proof-
of-concept HIV vaccine trials (STEP and Phambili) using a HAdV-C5-vectored vaccine, were
interrupted due to lack of efficacy and, unexpectedly, an increased risk of HIV acquisition in
some vaccinees [34,35]. Importantly, early HIV acquisition in vaccinees correlates with pre-
existing B and T-cell immunity targeting HAdV-C5 [35]. Potential explanations for higher
HIV infection rates are that IC-HAdV are potent driver of DCmaturation, which in turn
induces CD4 T-cell activation and proliferation [36], or proliferation of anti-AdV Th17 CD4 T
cells with mucosal homing [37–39], which makes them primed targets for HIV infection.
The ubiquitous HAdV humoral immunity and its impact on omnipresent wild type HAdV
encounters and during HAdV vector use, led us to investigate the molecular and cellular events
following IC-HAdV uptake by human professional antigen-presenting cells (APCs). To
address this, we characterized IC-HAdV composition, internalization, trafficking and process-
ing, the role of protein VI endosomal lysis, and the PRR involved in HAdV-C5 detection.We
show that neutralizingAbs (NAbs) cluster multiple HAdV-C5 particles and render capsid
more stable at acidic pH. In monocyte-derivedDCs (MoDCs), IC-HAdV stimulate vesicular
DNA sensor TLR9 inducing TNF production, and then escape into the cytosol in a protein VI-
dependent manner. There, the HAdV-C5 genomes activate the AIM2 inflammasome forma-
tion, which leads to caspase 1 activation, IL-1β processing, GSDMD cleavage, and loss of cell
membrane integrity. Our study provides a molecular basis to understand the source of the
adverse effects that have been observed in multiple clinical scenarios.
Materials andMethods
Cells and culture conditions
Human blood samples were obtained from anonymous donors at the regional blood bank
(EFS, Montpellier, France). An internal review board approved the use of human blood sam-
ples. MoDCs were generated from freshly isolated CD14+ monocytes in the presence of 50 ng/
ml granulocyte-macrophage colony-stimulating factor (GM-CSF) and of 20 ng/ml interleukin-
4 (IL-4) (PeproTech, Neuilly sur Seine, France) [40]. MoDC stimulations were performed at 6
d postisolation of monocytes. THP-1-ASC-GFP cells [41] were cultured like MoDC. 911 cells
[42] and 293T cells [43] were grown in Dulbecco’s modifiedEagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS).
Adenovirus vectors
Adβgal is a ΔE1/E3 HAdV-C5 vector harboring a lacZ expression cassette [44]. AdL40Q is a
HAdV-C5-based vector with a leucine to glutamine mutation of amino acid 40 in protein VI
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that decreases its membrane lytic activity [45]. AdL40Q was used within 3 months post-propa-
gation/purification [46]. Ad2ts1, from the closely related HAdV-C2 type, harbors a mutation
in the protease which prevents encapsidation and this results in several unprocessed capsid
proteins (IIIa, VI, VII, VIII, TP and mu) and a hyperstable capsid [47,48]. Alexa555- and Alex-
a488-HAdV-C5 (referred to as HAdV-555 and HAdV-488, respectively) were generated from
Adβgal by using a Alexa555 or Alexa488 Protein Labeling Kit (Life Technologies) as previously
described [49]. Vectors were purified to homogeneity by two CsCl density gradients as previ-
ously described [44]. Empty HAdV-C5 capsid are generated during vector production. They
are less dense and are easily separated from intact capsids by isopycnic CsCl centrifugation.
Immune complex formation and DC stimulation
MoDCs (4 x 105 in 400 μl of complete medium) were incubated with HAdV-C5 vector, or
IC-AdV (both 2 x 104 physical particles (pp)/cell, unless indicated).We generated IC-HAdVs
by mixing the virus (8 x 109 pp, or 2 x 104 pp/cell) with 2.5 μl of IVIg (human IgG pooled from
between 1,000 and 50,000 donors/batch) (Baxter SAS, Guyancourt, France) for 15 min at room
temperature. IVIg is used in patients with primary or acquired immune deficiencies as well as
autoimmune diseases. A synthetic oligodeoxynucleotide (ODN) containing the immunosup-
pressive motif TTAGGG that block TLR9 and AIM2 signaling (ODN A151 [50]) was added
2 h before stimulation. ODN A151 was synthesized by IDT. TLR4 agonist lipopolysaccharide
(LPS) (Sigma) and NLRP3 inducer nigericin (Invivogen) was used at 100 ng/ml and 10 μM,
respectively. Z-VAD (InvivoGen), WEHD (Santa Cruz) and YVAD (InvivoGen) were added
1 h before stimulation at 20 and 100 μM. MoDCs (4 x 105 in 400 μl of complete medium) were
incubated with HAdV-C5 vector, or IC-HAdV (both 2 x 104 physical particles (pp)/cell, unless
indicated) for indicated time.
Quantificationof virus internalization
Virus internalization was determined by qPCR as previously described [51,52]. Briefly, MoDCs
were incubated on ice with Adβgal, IC-HAdV or IgG for 30 min prior to incubation for up to 6
h at 37°C. To distinguish between extracellular and internalized virus, samples were divided
into two equal aliquots. In one of these, cell surface-associated virus was removed by acid wash
in one sample as previously described [52]. Briefly, cells were washed three times with ice-cold
PBS followed by 0.2 N acetic acid, 0.5 M NaCl, pH 2.5. Residual plasma membrane-associated
virus was removed by incubation with 2.5 mg/ml pronase XIV with 0.025 μg/ml DNase in
RPMI at 4°C for 1 h. DNA from acid-washed and the mock-treated samples were extracted as
previously described [53]. Viral genomes/cell were compared to standard curves and then nor-
malized to GAPDH.
RNA interference
Lentivirus vectors harboring shRNA expression cassettes were purchased from Open BioSys-
tems or designed in house. Targeted genes and shRNA sequence clones are listed in S1 Table.
To prepare lentivirus vectors, nearly confluent 293T cells were cotransfectedwith pLKO-
shRNA, pCMV-ΔR8.91 (gag/pol) and pCMV-VSVG using TurboFect (Thermo Scientific).
Helper particles were produced in 293T co-transfectedwith pSIV3+ and pCMV-VSVG [54].
One day posttransfectionmediumwas replaced by fresh medium. Supernatants were collected
36 h posttransfection and used immediately to transduce freshly isolated monocytes plated at 2
x 106 cells/well of a 6-well plate in 2 ml of complete medium. One milliliter of 0.45 μm-filtered
lentivirus vector supernatant made with 2 shRNAs clones targeting the same gene and 0.5 ml
of supernatant containing helper particles were added to each well. Polybrene (1 μg/ml), IL-4
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(20 ng/ml) and GM-CSF (50 ng/ml) were immediately added. Approximately 80% of DCs
were transduced (as observedby flow cytometry) 6 d postincubation as observedby flow
cytometrywhen using lentivirus vectors harboring a GFP expression cassette. shRNA knock-
down efficacywas checked by western blot. THP-1-ASC-GFP cells were also transduced by
lentiviral particles coding for shRNAs with 1 μg/ml polybrene. Transduced THP-1-ASC-GFP
cells were kept undifferentiated until their use in pyroptosis assays.
Pyroptosis assay
THP-1-ASC-GFP cells were differentiated into DCs over 6 d in complete medium supple-
mented with IL-4 (20 ng/ml) and GM-CSF (50 ng/ml) (PeproTech). Differentiated THP-
1-ASC-GFP cells were plated in 24-well plates at 105 cells/well in 200 μl of complete medium.
These cells were pretreated with Z-VAD-FMK (50 μM) for 30 min to prevent cell death, and
then exposed to HAdV-C5 vector, IVIg or IC-HAdV for 1 h. Whole cells were centrifuged
onto glass slides at 650 RPM for 5 min using cytospin, washed once with PBS, fixed with 4%
paraformaldehyde (15 min at room temperature), mounted with DAKO fluorescent mounting
medium containing 10 μg/ml DAPI (Sigma) and observedby fluorescent microscopy [41].
GFP loss (decrease in mean fluorescent index) and extracellular LDH activity were used as a
proxy for cell loss of membrane integrity because of the ease of measuring GFP fluorescent
intensity by flow cytometry and LDH activity in the supernatant.
For quantification of pyroptosome formation in MoDC,MoDCwere seeded at 1.2 x 105
cells/well in 500 μl complete medium on poly-L-lysine (Sigma)-coated coverslip in a 24-well
plate. The cells were attached to the coverslip by centrifugation at 1000 RPM and incubated for
several hours at 37°C/5%CO2. MoDCwere incubated with 20 μM Z-VAD or 100 μMODN
A151 where indicated for 2 h and then challenged by DNA transfection or 20,000 pp/cell
IC-HAdV, HAdV-C5 or 1.5 μl of IVIg for 3 h. Cells were fixed with 4% paraformaldehyde, per-
meabilizedwith 0.1% Triton X-100 and stained with mouse anti-ASC antibody (dilution
1:100) and corresponding fluorescently-labelled secondary antibody. Cover slips were mounted
with DAKO fluorescent mounting medium containing 10 μg/ml DAPI. For quantification, 70
to 700 MoDC from 2 donors were manually counted using confocal microscopy per condition
to identify puncta or diffuseASC signals. Ratios between cells and cells containing pyropto-
somes were calculated.
Western blot and antibodies
Total protein extracts were prepared by using RIPA buffer (10 mM Tris-Cl (pH 8.0), 1 mM
EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.1% sodiumdeoxycholate, 0.1% SDS, 140 mM
NaCl) plus protease inhibitors (Roche) and phosphatase inhibitor (Roche). Protein lysates
were used for SDS PAGE followed by western blot analyses. Primary antibodies were detected
using HRP-conjugated secondary antibodies against rabbit or mouse (Sigma) at a dilution of
1:10000. Antibodies used in this study for western blot include: mouse anti-β-tubulin (T4026,
Sigma), (dilution 1:15000), rabbit anti-MyD88 (Ab2064, AbCam) (dilution 1:500), rabbit anti-
AIM2 (Ab76423, AbCam) (dilution 1:1000), rabbit anti-TLR9 (Ab52967, AbCam) (dilution
1:250), mouse anti-AP3B1 (WH0008546M6, Sigma) (dilution 1:500), rabbit anti-IL-1β (#sc-
7884, Santa Cruz Biotechnology) (dilution 1:500), anti-GSDMD (G7422, Sigma) (1:1000).
Quantificationof mRNA
Expression levels of NLRP3 and AIM2 genes were analyzed using qRT-PCR. Total RNA was
isolated from DCs using the High Pure RNA isolation Kit (Roche) with a DNase I treatment
during the purification and eluted in 50 μl of DEPC-treated water. Reverse transcription was
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performedwith the Superscript First-Strand Synthesis System (Invitrogen) using 8 μl of total
RNA and random hexamers. The cDNA samples were diluted 1:6 in water and analyzed in
triplicate using a LightCycler 480 detection system (Roche). SYBR green PCR conditions were
95°C for 5 min and 45 cycles of 95°C for 15 s, 65°C or 70°C for 15 s, and 72°C for 15 s using
GAPDH sequences as standard. Primer sequences were as follows for NLRP3 (5’-CCTCTC
TGATGAGGCCCAAG-3’ (NLRP3 forward) and 5’-GCAGCAAACTGGAAAGGAAG-3’
(NLRP3 reverse)) at 65°C, AIM2 (5’-GCTGCACCAAAAGTCTCTCC-3’ (AIM2 forward) and
5’-TCAAACGTGAAGGGCTTCTT-3’ (AIM2 reverse)) at 65°C, IL-1β (5’-AAACAGATG
AAGTGCTCCTTCC-3’ (IL-1β forward) and 5’-AAGATGAAGGGAAAGAAGGTGC-3’
(IL-1β reverse) at 65°C, GAPDH (5’-ACAGTCCATGCCATCACTGCC-3’ (GAPDH forward)
and 5’-GCCTGCTTCACCACCTTCTTG-3’ (GAPDH reverse) at 70°C. Relative gene expres-
sion levels of each respective gene were calculated using the threshold cycle (2-ΔΔCT) method
and normalized to GAPDH [55].
IC-HAdV size
The size of HAdV-C5 and IC-HAdV complexes was determined using a light scattering device
(NanoSight NS500, NanoSight, Amesbury, UK). After the incubation of HAdV-C5 with NAb,
samples were diluted with Dulbecco’s PBS to reach a concentration of approximately 1 x 107
particles/ml).NanoSight LM10 recorded 60 s sample videos, which were then analyzed in the
Nanoparticle Tracking Analysis (NTA) 2.0 Analytical software release version build 0125
(NanoSight). The NTA software technology uses the properties of both light scattering and
Brownian motion to obtain the size distribution and concentration measurement of particles
in liquid suspension [56]. All samples were run twice and analyzed separately.
Flow cytometry
Surface levels of CD40 and CD86 were assessed by flow cytometry as previously described [40].
Cell membrane integrity was assessed by collecting cells by centrifugation 800 x g, the cell pel-
lets were resuspended in PBS, 10% FBS, propidium iodide (Sigma) or 7-aminoactinomycin D
(Becton-Dickinson)and analyzed on a FacsCalibur flow cytometer (Becton-Dickinson).
IC-HAdV mean diameter was assessed using an LSR Fortessa flow cytometer (Becton-Dick-
inson) for microparticle analysis as previously described [57]. HAdV-555 alone, IgG or
IC-HAdV-555 were identified by side scatter and fluorescence. Size was determinedwith
TransFluoSpheres 1.0 μm (Life Technology) and SpheroCalibration Particles 3 μm (Becton-
Dickinson).
Caspase 1 assay
Caspase 1 activation was determined using the FLICA Apoptosis DetectionKit for Caspase-1
(ImmunochemistryTechnologies) according to the manufacturer’s guidelines with slight mod-
ifications. In brief, MoDCwere preincubated with 2.5 μM FAM-YVAD-FMK FLICA for 30
min and incubated to 20,000 pp/cell HAdV-C5, IVIg, IC-HAdV, LPS or LPS/nigericin as
described in the section “Immune complex formation and DC stimulations” for 3 h. Subse-
quently, cells were collected by centrifugation and washed twice with the apoptosis buffer.
Fluorescence of the cells was assessed using flow cytometry.
LDH assay
LDH release was determined using the LDH cytotoxicity kit (Pierce) according to the manufac-
turer’s guidelines. Briefly, 50,000 MoDCwere plated in 100 μl in 96-well plates and exposed to
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20,000 pp/cell HAdV-C5, IVIg, IC-HAdV or LPS/nigericin in triplicates as described in the
section “Immune complex formation and DC stimulations” for 6 h. LDH activity in cell culture
supernatants was detected using the kit reagents and calculated according to the 100% LDH
release control from lysed cells.
Electron and fluorescencemicroscopy
MoDCs were incubated for 3 h with HAdV-C5, IVIg or IC-HAdV and subsequently prepared
for thin section transmission electronmicroscopy (TEM) to visualize internalized immune-
virus complexes as previously described [58]. For confocal immunofluorescencemicroscopy,
MoDCs were seeded on poly-L-lysine coated cover slips for 60 min at 37°C followed by incuba-
tion with HAdV-C5 or IC-HAdVs. Postincubation, cells were fixed, permeabilized and stained
with indicated primary antibodies and fluorophore labeled secondary antibodies. Confocal
microscopy analysis was carried out using a Leica SP5 (Leica). Primary antibodies for immuno-
fluorescence included rabbit anti-AIM2 (HPA031365, Sigma) (dilution 1:100); mouse anti-
ASC (D086-3, MBL) (dilution 1:100) mouse anti-p62/sqstm1 (Ab56416, AbCam) (dilution
1:100) mouse anti-galectin-3 (B2C10, Becton-DickinsonPharmingen) (dilution 1:100). Blue,
green, red, and far-red fluorescencewere acquired sequentially.
Cytokines secretion
Supernatants were collected and secretion of TNF and IL-1β was quantified by ELISA using
OptEIA human TNF ELISA Kit (BectonDickinson) and human IL-1β/IL-1F2 DuoSet ELISA
(R&D systems) following the manufacturer’s instructions.
Serumdepletion
Antibodies against HAdV-C5 capsid proteins were depleted from IVIg using Pure proteome
NHS FlexiBindMagnetic Beads (Millipore). One hundred microliters of 20% beads were incu-
bated overnight with 30 μg of recombinant capsid proteins on a rotary shaker at 4°C. Beads
were collectedwith a magnetic rack (Millipore) and washed 7 times with 1 ml PBS to remove
unbound proteins. After a final wash, the beads were resuspended in 200 μl of NAbs diluted 1:4
in PBS and incubated on a rotary shaker overnight at 4°C. Beads were then removed from
depleted serumwith a magnetic rack. Antibodies bound on protein-bead complexes were
eluted by incubation of beads in 165 μl of 0.1 M glycine (pH 2.7) for 2 min at room temperature
and beads were removed from suspension with a magnetic rack. Thirty-fivemicroliters of 1 M
Tris-Cl, pH 8 was added to neutralize the pH of the solution. Mock controls were the same
beads incubated in PBS instead of HAdV-C5 capsid proteins.
Capsid stability assay
HAdV-C5 vector alone (6 x 109 pp), IVIg (10 μg) or IC-HAdV were exposed to pH 5 (sodium
acetate), pH 6 (MES), pH 7 (HEPES) or pH 9 (carbonate buffer) buffers (15 μl final volume)
and capsid disassembly was assessed by DNA detection using Picogreen fluorescent dye (Invi-
trogen). The ABI prism 7900HT PCRmachine (Applied Biosystems) was programmed to mea-
sure fluorescence (λex = 488 nm and λem = 520 nm) every 2.5°C from 30 to 70°C.
Statistical analysis
All experiments were performed a minimum of three independent times and expressed as
mean values ± SD unless otherwise stated. Comparisons of groups for statistical difference
were performed using Student’s t-test. A p value of<0.05 is denoted as significant.
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Results
Anti-hexon antibodies crosslink and stabilize HAdV-C5, and induce DC
maturation
We previously showed that when HAdV-C5 is pre-incubated with human serum containing
HAdV-C5 NAbs, the mix efficiently induce Fcγ-receptor (FcγR)-dependentMoDCmaturation
[36]. Previous reports also demonstrate that human sera or an adaptor made up of the extracel-
lular fragment of the coxsackievirus and adenovirus receptor (CAR [59,60]) and the Fc portion
of a human IgG increase HAdV-C5 internalization by FcγR-expressing cells [31,61]. Here, we
compared the uptake of internalized capsids following incubation of HAdV-C5 or IC-HAdVs
in MoDCs and found>10-fold more genomes internalized/cell at 6 h when using IC-HAdV
(S1 Fig). These data are consistent with our previous studies using fluorescently labelled
HAdV-C5 [62]. While MoDCmaturation correlates with NAb titers, we could not formally
exclude that other serumproteins influenceMoDCmaturation. To determine if IgG alone
could induceMoDCmaturation, we used pooled human IgGs (IVIg) to generate IC-HAdVs.
In the presence of a fixed concentration of HAdV-C5 and increasing concentration of IVIg,
MoDCs secrete increasing levels of TNF (Fig 1A). Neither HAdV-C5 nor IVIg induces signifi-
cant levels of TNF after 6 h of incubation. Like our previous results using sera [36], IC-HAdVs
made with IVIg induce higher levels of cell surface expression of co-stimulatorymolecules
CD40 and CD86 (S2A Fig). In addition, IC-HAdVs made with sera or IVIg induce a notable
change in the size and granularity in ~40% of the cells (S2B Fig).
IC-HAdVs can be found in the systemic circulation during HAdV-C5 infection, and post-
mortem in tissues following fatal viremia [8,9]. Because the composition of IC-HAdVs could
vary, we analyzed the size of IC-HAdV by flow cytometry and by nanoparticle tracking based
on Brownian motion (NanoSight). Flow cytometryhas a lower limit of ~1 μm, while NanoSight
has an upper limit of ~1 μm in diameter. Using these complementary approaches, we found
that most IC-HAdVs generated at 37°C for 2 h in PBS have a mean diameter of 200 nm prior
to incubation with the cells (Fig 1B and 1C). Because an HAdV-C5 capsid is ~90 nm in diame-
ter, these data suggest that in these conditions the majority of IC-HAdV have ~4 HAdV-C5
particles/complex.
Following engagement of receptor(s) on epithelial-like cells, HAdV-C5 is endocytosed in
clathrin-coated pits. Then, HAdV-C5 escape from endocytic vesicles into the cytoplasm is con-
comitant with an acidification of the vesicles and prior to fusion with lysosomes [63]. The
escape mechanism is thought to prevent HAdV-C5 from being degradedwhen the endocytic
vesicles fuses with lysosome-like structures. By contrast, DCs delay acidification of some endo-
cytic vesicles, which promotes more efficient antigen degradation for cross-presentation
[64,65]. This is particularly efficient for IC antigens that are taken up by FcγRs [66–68].
BecauseHAdV-C5 alone poorly induce the maturation of MoDCs, it is likely that the NAb
influence IC-HAdV trafficking.NAbs function differently depending on the targeted capsid
protein. Anti-fiber NAb and anti-penton NAb likely impair cell surface receptor engagement
[69], while hexon-NAb prevent extracellular recruitment of bridgingmolecules, intracellular
capsid disassembly and/or recruitment of microtubule-associatedmotor proteins following
endosome escape [70,71]. We therefore asked whether HAdV-C5 capsid stability changed fol-
lowing incubation with IVIg. To address capsid stability, we used accessibility of viral DNA to
intercalating fluorescent dyes as a proxy to quantify capsid integrity/stability. Increased fluores-
cent intensity (decreased capsid integrity) was measured at pH 7 and 6 and at increasing tem-
perature. At pH 7, we found similar kinetics for capsid disassembly for HAdV-C5 and
IC-HAdV (Fig 1D, left panel). At pH 6, the fluorescence is higher for HAdV-C5 than for
IC-HAdV throughout the temperature change below 55°C, indicating increased capsid stability
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in presence of NAbs (Fig 1D, right panel). Using chimericHAdV capsids we previously showed
that anti-hexon were responsible for the induction of DCmaturation [72]. To address the role
of anti-hexon Abs using another approach, we depleted them from IVIg and found that this
decreases TNF secretion at 3 and 6 h postincubation (Fig 1E). Consistent with this, forming
IC-HAdV with anti-hexon-Ab-depleted serum plus the respective eluate partly restored phe-
notype in a dose-dependentmanner.
Together, these data demonstrate that MoDCmaturation depends on IgG-HAdV-C5 com-
plexes that contain ~4 HAdV-C5 capsids, increase uptake in MoDC, and the stabilizing anti-
hexon Abs play a notable role in DCmaturation.
IC-HAdVs induce TNF production via TLR9 engagement
During FcγR-mediated uptake of immune-complexed cargo, TLR9 is also processed and deliv-
ered to lysosome-like compartments [73]. We reasoned that if NAb stabilize the HAdV-C5
capsid this should favor fusion of IC-HAdV-containing vesicles with TLR9+ vesicles and the
induction of transcription of pro-inflammatory cytokines. Of note, using a TLR9 antagonist
(IRS 869) we previously showed that IC-HAdV engage TLR9 [36]. Because pharmacological
approaches can have off-target effects, we addressed the role of TLR9, its signaling adapter
MyD88, and AP3B1, which is involved in TLR9 targeting to lysosome-related vesicles [74], by
lentivirus-mediated shRNA knockdown. To circumvent SAMHD1 (sterile alpha-motif domain
and His-Asp domain-containing protein 1)-mediated restriction of lentivirus infection of
human monocytes, we generated lentivirus particles containing Vpx [54,75]. We also trans-
duced freshly isolated monocytes prior to differentiation into DCs. Using this approach, ~90%
of the monocytes are routinely transduced with the lentivirus vectors without inducing or pre-
venting MoDCmaturation. Although shRNA-mediated knockdown of TLR9, MyD88 and
AP3B1 were partial (Fig 2A), TNF secretion is reduced in TLR9-pathway impaired cells (Fig
2B). We previously showed that IC-HAdV induce accumulation of IL1BmRNA in unprimed
THP-1-derived DC [62]. We therefore asked whether IC-HAdV induce IL1B transcription in
MoDC.We quantified IL1BmRNA levels by qRT-PCR at 3 and 6 h postincubation (Fig 2C).
We found that MoDCs contain relatively low levels of IL1BmRNA with this classic differentia-
tion protocol, while both LPS and IC-HAdV induce IL1B transcription and pro-IL-1β produc-
tion (Fig 2D).
These data are consistent with our previous results [36] demonstrating that the HAdV
genome is detected by the vesicular PRR TLR9, and induce production of pro-inflammatory
cytokines.
IC-HAdVs reach the cytoplasm
The above data point towards a process where HAdV-C5 capsids are disassembled in TLR9+
compartments, which should lead to protein VI release and disruption of the membrane [76].
Fig 1. Immune-complexed HAdV-C5: role of IgGs, physical characteristics, and anti-hexonAbs. The effect of IgG-opsonization
on HAdV-C5 particlesize, stability, and aggregation, and how it affects MoDCmaturation was assessed. A) TNF secretion by MoDCs
incubatedwith LPS, HAdV-C5, IVIg and IC-HAdV formed using a fixed dose of 20,000 pp/cell HAdV-C5 and increasing volume of
pooled human IgGs (IVIg). B) Size of HAdV-C5, IC-HAdV and IVIg was assayed by nanoparticle tracking. IC-HAdVwere formed in
PBS for 2 h at 37°C. C) Size of IC-HAdV-555 by flow cytometry. Fluorescent beads of 1 and 3 μmwere used to determine the
diameter of IC-HAdV based on side scatter (SSC). D) Fluorescent intensity used as a surrogate for capsid stability: the stability of
HAdV-C5 or IC-HAdVwas assessed at pH 6 and 7 at increasing temperatures by monitoring HAdV-C5 genome accessibility to
Picogreen. E) Immune complexes were generated using either IVIg, mock-depleted IVIg (NAbsΔCtrl), IgG recovered frommock-
depleted IVIg (NAbs fromΔCtrl), from IVIg depleted for hexon-antibodies (NAbsΔα-hexon), or purifiedanti-hexon Abs (NAbs fromΔα-
hexon). MoDCswere incubated with HAdV-C5, IC-HAdV, IVIg for 3 or 6 h. TNF secretionwas quantified by ELISA. All assays were
repeated at least three timeswith similar results.
doi:10.1371/journal.ppat.1005871.g001
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We therefore used confocal microscopy to determine whether IC-HAdV induce membrane
rupture. We focused on colocalization of Alexa488-labeledHAdV-C5 (HAdV-488) and
IC-HAdV-488 with p62/sqstm1 and galectin-3. p62/sqstm1 is recruited to membrane rem-
nants as part of the intracellular damage response and targets these remnants via binding to
galectin-3 [77]. We found that p62/sqstm1 (Fig 3A) and galectin-3 (Fig 3B) colocalizewith
large IC-HAdV aggregates at 3 h postincubation, demonstrating disruptedmembranes. We
then used transmission electronmicroscopy (TEM) to visualize IC-HAdV at 30 min postincu-
bation. In contrast to the ~200 nm aggregates detected in solution, we detect larger aggregates
being internalized, and insideMoDCs (Fig 3C). Consistent with previous reports [61], the
internalized of IC-HAdVs are not enclosed by membranes (Fig 3C). Together, these data dem-
onstrate that IC-HAdVs begin to disassemble in TLR9+ endocytic vesicles, rupture their mem-
branes, and escape into the cytoplasm.
IC-HAdV-induced loss of cell membrane integrity
To further understand the IC-HAdV-induced change in MoDCs size and granularity we
assayed membrane homeostasis. Of note, PMA-differentiated THP-1 cells primed with
Fig 2. IC-HAdV induceMoDCmaturation throughDNA sensors TLR9. TNF secretion in response to IC-HAdVwas measured in
MoDCs after lentivirus-mediated shRNA knockdown of TLR9,MyD88 and AP3B1. A) Immunoblotting demonstrating lentivirus-mediated
shRNA knockdown of the TLR9 pathway in MoDC. MoDCswere exposed to LPS, HAdV-C5, IC-HAdV or IVIg for 3 and/or 6 h and B)
TNF secretionwas measured by ELISA. C) IL1BmRNA levels were assessed by qRT-PCR. D) Immunoblots of pro-IL-1β levels in
MoDCs after incubation with HAdV-C5, IC-HAdV, IVIg or LPS at 6 h. β-tubulin levels were used as loading controls. The experiments
were carried out in 2–3 donors with similar results.
doi:10.1371/journal.ppat.1005871.g002
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PAM3CSK4, a TLR1/2 agonist, and then exposed to 200,000 HAdV-C5 pp/cell lose plasma
membrane integrity [28,78]. To determine if IC-HAdVs induce the loss of plasma membrane
integrity we compared the effect of HAdV-C5 and IC-HAdV onMoDC. As markers for loss of
membrane integrity we quantified propidium iodide (PI)+ entry into cells by flow cytometry
and loss of intracellular proteins. Using a dose-dependent assay, we found that IC-HAdV
made with as little as 5,000 HAdV pp/cell start to induce an increase in the number of PI+ cells
at 6 h, which reached ~40% of the cells when using 20,000 HAdV pp/cell in this donor (Fig
4A). IC-HAdV-induced loss of plasma membrane integrity could be due to intrinsic or extrin-
sic factors. HAdV-C5 super-infectionmay induce loss of membrane integrity via intracellular
ROS production and cathepsin release into the cytosol [28,78]. In addition, infection of mouse
cells with HAdV-C5 leads to the release of cellular components (e.g. ATP), which are associ-
ated with the death of bystander cells [79,80]. To determine if IC-HAdV-mediated MoDC
death is associated with direct interaction with IC-HAdV or a paracrine effect, we assayed
MoDC interaction with IC-HAdV-555, an immune complex made using HAdV-555 (an Alex-
a555-labeledHAdV-C5). We found that all PI+ MoDCs are associated with IC-HAdV-555
Fig 3. IC-HAdV inducemembranedamage and gain access to the cytosol.MoDCswere exposed to Alexa488-HAdV-C5, IC-HAd-488 or IVIg
for 3 h and processed for confocal immunofluorescence analysis and stainedwith anti-p62 (n = 3) A) and galectin-3 (n = 3) B). Scale bar = 5 μm. C)
Transmission electronmicroscopy of IC-HAdV in MoDCs at indicated times. HAdV-C5 can be seen due to their high electron density. White lines
depict circumference of IC-HAdVs.White asterisks indicate artifacts.
doi:10.1371/journal.ppat.1005871.g003
Fig 4. IC-HAdV induce loss of plasmamembrane integrityand release of cytosolic proteins fromMoDC.MoDCswere challengedwith
IC-HAdV and plasmamembrane integrity, LDH and GFP releasewas quantified. A) MoDCswere incubated with IVIg, HAdV-C5 and IC prepared
with an escalating dose (100, 1,000, 2,000 5,000, 10,000 15,000, 20,000 pp/cell) of HAdV-C5 and cell membrane integritywas assessed by
intercalationof propidium iodide (PI) into cellular DNA at 6 h. B) MoDCswere incubatedwith Alexa555-HAdV-C5, IC-HAdV-555 or IVIg and
assayed by flow cytometry at 6 h. The quadrants were set for PI- HAdV-C5- (white), PI- HAdV-C5+ (light grey), PI+ HAdV-C5+ (dark grey) and PI+
HAdV-C5- (black). The percentageof each subpopulation at each condition is depicted in the histogram. These assays were performed in 3 donors
with similar results. C) Loss of cytosolic content by MoDC exposed to IC-HAdV, IVIg, HAdV-C5 and LPS/nigericinwas assessed by measuring
LDH activity in the supernatant. D) Loss of cytosolic content by GFP-lentivirus transducedMoDCexposed to IC-HAdV, IVIg, HAdV-C5 and LPS/
nigericinwas assessed by flow cytometry measuringGFP fluorescent and plasmamembrane integritywith PI.
doi:10.1371/journal.ppat.1005871.g004
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(Fig 4B), suggesting that a direct interaction is responsible for the loss of plasma membrane
integrity. These data demonstrate that PI, a small membrane impermeable DNA intercalator
can enter IC-HAdV-challenged MoDCs.
To determine if the MoDC also lose intracellular proteins, we assayed extracellular levels of
L-lactate dehydrogenase (LDH) activity and the loss of intracellular GFP in MoDC.We com-
pared the maximum LDH activity in the supernatant of control and IC-HAdV-challenged
MoDCs and found that IC-HAdV induce a level similar to LPS/nigericin (Fig 4C). To address
this using another approach we transducedmonocytes with a lentivirus vector expressing GFP,
differentiated them into MoDCs, and challenged them with IC-HAdVs. We found that neither
IVIg or HAdV-C5 significantly decreased the percentage of GFP+MoDCs, while incubation
with IC-HAdVs reduced the GFP population by ~40% (Fig 4D). Together, these data demon-
strate that IC-HAdV-induced loss of cell membrane integrity.
Protein VI and the HAdV genome are involved in loss of cell membrane
integrity
To address the cause of IC-HAdV-mediated membrane permeabilization,we initially focused
on the capsid components that likely influence IC-HAdV-mediated MoDC death. Endosomal
escape of HAdV-C5 and induction of the NLRP3-inflammasome are linked in THP-1 cells
[28,78] and therefore a similar mechanismmight occur in primary human APCs. To address
this possibility, we used Ad2ts1, which harbors a mutation in protease and results in a hyper-
stable capsid [47,48]. In contrast to IC-HAdV, IC-empty capsids do not induce loss of mem-
brane integrity, while IC-Ad2ts1 induce ~4-fold less (Fig 5A), suggesting that internal capsid
components are linked to loss of membrane integrity.
We then focused on the role of the internal capsid protein VI. HAdV-C5 endosomal escape
in epithelial cells depends on the membrane lytic capacity of protein VI [81]. Using AdL40Q, a
HAdV-C5 vector containing a L40Qmutation in protein VI that causes attenuation in protein
VI membrane lytic activity [45,46,82] we compared plasma membrane integrity in presence of
Fig 5. Protein VI is indirectly linked to loss of plasmamembrane integrity.MoDCswere challengedwith IC prepared from
HAdV-C5 and HAdV-C5 harboringmutations in protein VI or protease. A) Effect on cell membrane integritywas determinedby
incubating MoDCswith HAdV-C5, Ad2ts1 and HAdV-C5 empty capsid or IC of each virus, respectively (n = 3) for 6 h, then with PI
followed by flow cytometry. B) Dose-dependent loss of cell membrane integritywas assessed for IC-HAdV and IC-AdL40Qat 6 h (n = 5)
as in B. Statistical significance (p values) were derived from two-way ANOVA with Bonferonni post test: * and ** correspond to p < 0.05
and p < 0.01, respectively.
doi:10.1371/journal.ppat.1005871.g005
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IC-AdL40Q versus IC-HAdV in a dose-dependent assay. We found that IC-AdL40Q induces
less plasma membrane disruption (Fig 5B) compared to IC-HAdVs. These data demonstrate
that the membrane lytic activity of protein VI and the viral genome influence plasma mem-
brane homeostasis.
IC-HAdVs induce and colocalize with AIM2 inflammasomes
Our data indicate that IC-HAdV traffic through endosomal compartments until they fuse with
a TLR9+ vesicle. DNA and protein VI are likely release from the capsid here, leading to TLR9
signaling and escape into the cytosol to induce viral genome-dependent loss of membrane
integrity. Pioneering work by Wiethoff and colleagues showed that HAdV-C5 can activate the
NLRP3 inflammasome in super-infected THP-1 cells, and in human monocyte-derivedmacro-
phages [78]. We therefore asked whether the NLRP3 pathway is being activated in IC-HAdV-
challengedMoDCs. Although the mechanism is poorly understood, the NLRP3-mediated
inflammasome activation is critically dependent on K+ efflux.We therefore increased the extra-
cellular concentration of K+ to block the NLRP3 pathway and found that this had no effect on
the loss of MoDCmembrane integrity upon challenge with IC-HAdV (S3A and S3B Fig). Simi-
larly, MCC950, an inhibitor of canonical and noncanonical NLRP3 activation did not prevent
the loss of membrane integrity (S3C Fig). From these data we concluded that the NLRP3
inflammasomewas not activated in unprimed human MoDCs.
In addition to the NLRP3, inflammasome formation can be induced by AIM2, IFI16,
NLRP1, NLRC4 pathways [83]. BecauseAIM2 detects foreign dsDNA, its potential role in
IC-HAdV-challenged MoDCs was investigated. Monocytes are classically differentiated into
MoDCs in presence of GM-CSF and IL-4. Of note, IL-4 can inhibit IL-1β secretion and NLRP3
inflammasome induction in a non-transcriptional manner [84,85]. Moreover, compared to
monocytes,MoDCs secret notably less IL-1β in response to TLR2/4 agonists and heat-killed
bacteria [86]. By contrast, IL-4 does not affect the AIM2 inflammasome components [85], and
cytosolicDNA stimulates upregulation of AIM2mRNA levels and AIM2 inflammasome acti-
vation in MoDCs [87]. We therefore quantifiedNLRP3 and AIM2mRNA levels in freshly puri-
fiedmonocytes, immature MoDCs, and in MoDCs incubated with IC-HAdV or LPS.We
found that in MoDCs,NLRP3mRNA levels are approximately 10-fold lower than in mono-
cytes and, in contrast to LPS and IC-HAdV, do not increaseNLRP3mRNA levels (S4A Fig).
By contrast, AIM2mRNA levels are modestly increased during monocytes differentiation into
MoDC, and are upregulated in response to LPS and IC-HAdVs (S4B Fig). We therefore used
the lentivirus shRNA approach to reduce AIM2 levels in MoDCs (S4C Fig). Following AIM2
reduction and IC-HAdV challenge, we found that TNF levels increase compared to controls
(Fig 6A). These data suggest an impaired AIM2 inflammasome formation, prolonged survival
of MoDC, and a continued production and secretion of TNF stimulated by upstream TLR9
engagement.
The assembly of the AIM2 inflammasome is a two-step process. First, several AIM2mole-
cules bind to DNA via the C-terminal HIN200-domain and oligomerize through protein-pro-
tein of the respective pyrin domains [88]. The ability to oligomerize is critical for dsDNA
binding and the length of DNA regulates the assembly of the AIM2 polymers. Second, AIM2
oligomerization leads to the recruitment of ASC, caspase 1, pro-IL-1β, and GSDMD. To deter-
mine if IC-HAdVs induce inflammasome formation, we used THP-1-derived DC expressing
an ASC-GFP fusion protein (THP-1-ASC-GFP [41]) to visualize inflammasome formation.
Under mock-treated conditions, ASC-GFP is dispersed throughout the cytoplasm (Fig 6B, top
left panel). After inflammasome assembly a GFP foci/cell can be detected [41]. We therefore
incubated THP-1-ASC-GFP DCwith IC-HAdVs and quantified pyroptosome formation. We
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found that IC-HAdVs induce>5-fold more (p< 0.05) inflammasomes than in mock-,
HAdV-C5-, or IVIg-challenged THP-1 cells (Fig 6C and 6D). We then repeated the shRNA-
mediated knockdown of AIM2 in THP-1-ASC-GFP cells. Knockdown of AIM2 reduces
inflammasome formation in response to IC-HAdVs (Fig 6D). Interestingly, knockdown of
TLR9 also reduces AIM2-associated inflammasome formation also (Fig 6D) in THP-1 cells.
These data suggest that the trafficking of the IC-HAdV through a TLR9+ vesicle may increase
the expression of AIM2 inflammasome components and/or formation.
Because in our hands in THP-1-ASC-GFP cells responded poorly to IC-HAdV challenge,
we also assayed pyroptosome formation in MoDCs. Here we found that IC-HAdVs induced at
least ~15-fold more pyroptosome+ MoDCs than controls (Fig 6E). Of note, these results likely
underestimate the percentage of MoDCs with pyroptosomes: there were consistently fewer
intact cells bound to the poly-L-lysine-coated coverslips capable to be analyzed by immunoflu-
orescence staining for ASC aggregates.
We then asked if pyroptosome formation is directly associated with the IC-HAdVs in
MoDCs. To address this question, we incubatedMoDCs with IC-HAdV-555 and screened for
AIM2 and ASC subcellular location by epifluorescence and immunofluorescence. Consistent
with our previous results, IVIg and Alexa555-HAdV-C5 alone do not induce inflammasome
formation (Fig 6F). By contrast, as early as 30 min postincubationAIM2 and ASC colocalized
with IC-HAdV-555 in large fluorescent aggregates (Fig 6F). To address AIM2 inflammasome
formation using another approach we pre-incubated cells with ODN A151, a competitive
inhibitor for DNA recognition by AIM2. ODN A151 can prevent AIM2-induced inflamma-
some assembly, caspase 1 induction, and IL-1βmaturation in APCs [50]. Following pre-incu-
bation of MoDCs with ODN A151 we found a dose-dependent inhibition of IC-HAdV-
induced loss of cell membrane integrity (Fig 6G). Importantly, pre-incubation with ODN A151
also rescuedMoDCs from loss of cell membrane integrity when cells are transfected with plas-
mid DNA (S5 Fig). Unexpectedly, ODN A151 did not efficiently prevent IC-HAdV IL-1β
secretion (Fig 6H). These data indicate that inhibition of cytosolicDNA sensing by AIM2 pre-
vents IC-HAdV-induced loss of cell membrane integrity, but not the release of IL-1β. Together,
these data demonstrate that IC-HAdV induce AIM2/ASC aggregates in human MoDCs.
IC-HAdVs induce pyroptotic MoDC death via the AIM2 inflammasome
Pyroptosis is a highly inflammatory form of cell death. The key determinants for pyroptosis are
pyroptosome formation (Fig 6), caspase 1 activation, IL-1β secretion, and loss of cell mem-
brane integrity (Figs 4 and 5) due to cleavage of GSDMD. Canonically, IL-1β is cleaved by
Fig 6. IC-HAdVs induceAIM2-associated pyroptosomes. Involvement of AIM2 and/or TLR9 in IC-HAdV-
induced inflammatory cell death was assessed by RT-qPCR, RNAi, pharmacological inhibitors, flow
cytometry, fluorescence microscopy and ELISA. A) Lentiviral-mediated shRNA knockdown of AIM2 in MoDC.
MoDCswere exposed to HAdV-C5, IC-HAdV or IVIg for 6 h and TNF secretionwas quantified by ELISA. B)
Fluorescent microscopy of THP-1 ASC-GFP-derived dendritic cells incubatedwith HAdV-C5, IC-HAdV or
IVIg.White arrows indicate ASC pyroptosomes (green). Nuclei were counter stainedwith DAPI (blue). Scale
bar = 20 μm. C) Percentage of pyroptosome formation in THP-1 ASC-GFP-derived dendritic cells 1 h
poststimulation. D) Percentage of pyroptosome formation in THP-1 ASC-GFP-derived dendritic cells after 1 h
exposure to IC-HAdV after shRNA knockdown of MyD88, TLR9 and AIM2. E) Percentage of pyroptosomes
(immune-labeledwith anti-ASC) in MoDC ± AIM2-inhibitor ODNA151 for 2 h and exposure to transfected
DNA, IVIg, HAdV-C5 and IC-HAdV for 3 h. F) MoDCswere exposed to Alexa555-HAdV-C5, IC-HAdV-555 or
IVIg for 3 h and processed for confocal immunofluorescence analysis and stainedwith anti-AIM2and anti-
ASC. Nuclei were counter stainedwith DAPI (blue) (n = 3). Scale bar = 5 μm.G) Loss of plasmamembrane
integritywas assessed by PI/flow cytometry in ODNA151-pretreatedMoDCs challengedwith IC-HAdVs.
MoDCswere exposed to 20,000 pp/cell HAdV-C5, IC-HAdV or IVIg after 2 h pre-incubation with 10 or 100 μM
ODNA151 H) Conditions as in G, IL-1β secretionwas quantified by ELISA at 6 h (n = 3).
doi:10.1371/journal.ppat.1005871.g006
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auto-activated human caspases 1 upon inflammasome formation. To address whether IL-1β is
secreted we incubatedMoDCs with IC-HAdV and quantified IL-1β levels in the supernatant.
We found that IC-HAdV induce a dose-dependent increase in secreted IL-1β levels (Fig 7A).
Due to our results demonstrating that IC-AdL40Q induces less plasma membrane disruption,
we also quantified the level of secreted IL-1β from IC-HAdV- and IC-AdL40Q-challenged
MoDCs. In these assays, we found less secreted IL-1β-induced by IC-AdL40Q at lower doses
(Fig 7A). These data suggest that endosomal escape is needed for the secretion of IL-1β.
The reports describing the involvement of caspase 1 in HAdV-C5-induced cell death vary.
While both HAdV-C5 and IC-HAdV induce caspase 1 activation and IL-1β processing in
THP-1 cells [30], the caspase 1 inhibitor YVAD does not inhibit the loss of membrane integrity
[78]. We therefore addressed the role of caspases in IC-HAdV-challenged MoDC.We incu-
bated cells with a pan-caspase inhibitor (Z-VAD) and an inhibitor for caspase 1 (YVAD) prior
to a challenge with IC-HAdVs. We found that both inhibitors significantly reduced the levels
of secreted IL-1β (Fig 7B), demonstrating that IC-HAdV induce caspase 1 activation. Of note,
Z-VAD did not prevent PI from entering cells (Fig 7C), suggesting that a caspase-independent
factor may be causing small holes in the plasma membrane. To address caspase 1 activation
using another approach, we incubated cells with the fluorescent probe FAM-YVAD-FMK
FLICA, which enters each cell and irreversibly and covalently binds to activated caspase 1. We
quantified the fluorescent cells by flow cytometry and found that ~40% of the cells contain acti-
vated caspase 1 (Fig 7D). Together, these data demonstrate that IC-HAdVs induce caspase 1
activation and IL-1β release.
Like caspase 1, GSDMD is recruitedwith similar kinetics and in similar amounts to pyrop-
tosomes [17]. To determine if IC-HAdV-challenge induces GSDMD cleavage we assayed
GSDMD cleavage by immunoblotting.We found that GSDMD is efficiently cleaved in
IC-HAdV-challenged MoDCs, and cleavage could be prevented by caspase 1-specific inhibitors
(YVAD andWEHD) as well as Z-VAD (Fig 7E). In addition, ODN A151, which inhibits AIM2
engagement of dsDNA, also reduced GSDMD processing (Fig 7F). Together, these data dem-
onstrate that IC-HAdVs induce the key determinants of pyroptosis in MoDCs.
Discussion
The aim of our study was to understand the impact of immune-complexed HAdV-C5 on
human APCs.We show that anti-HAdV-C5 hexon Abs aggregate and stabilized the capsid at
mildly acidic pH. The anti-hexon antibodies also perturb the intracellular trafficking of
HAdV-C5: instead of release from early endocytic vesicles, the IC-HAdV+-vesicles fuse with
TLR9+ vesicles. Here, the capsid must be partially disassembled to allow detection of the
genome by TLR9. TLR9 engagement induces the transcriptional activation of pro-inflamma-
tory cytokines and inflammasomes components via the MyD88-NF-κB signaling pathways.
Concomitant with genome release from the capsid, the membrane lytic activity of protein VI
impacts IC processing by permitting endocytic vesicle cargo escape into the cytoplasm. Here,
the 36 kb dsDNA HAdV genome is detected by AIM2, which initiates the nucleation of an
inflammasome. Recruitment and cleavage of caspase 1, pro-IL-1β and GSDMD culminate in
pyroptotic MoDC death (Fig 8).
The ex vivo human APCmodel
Monocytes are an evolutionarily conserved subset of highly phagocyticmononuclear cells that
originate frommyeloid progenitors in the bone marrow. They represent 10% of the white
blood cells, including reservoirs in the spleen and lungs. Monocytes are rapidly recruited to tis-
sues during infection and inflammation. Here, after exposure to pro-inflammatory cytokines
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Fig 7. IC-HAdV induced IL-1β expression, caspase-dependent IL-1β secretion and AIM2 inflammasome-dependent GSDMD
cleavage inMoDCs.The involvement of the AIM2 inflammasome and caspases in the inflammatory response in IC-HAdV challenged
MoDCs ± inhibitorswas assessed by quantifying intra- and extracellular levels of IL-1β plasmamembrane integrity and GSDMD
cleavage. A) Effect of protein VI-mediatedmembrane lytic activity on IL-1β secretionwas assessed by incubation of MoDCswith
escalating doses of IC-HAdV or IC-AdL40Q. IL-1β secretionwas quantified by ELISA (n = 5). P values were derived from two-way
ANOVA with Bonferroni posttest. * and ** correspond to p < 0.05 and p < 0.01, respectively. B) IL-1β secretion in MoDCs pre-incubated
with 20 μMYVAD and Z-VAD and stimulated as indicated. This experiment was performed in triplicateusing 3 donors with similar
results. C) Loss of cell membrane integritywas assessed by PI/flow cytometry for MoDCs pre-incubated with Z-VAD and exposure to
HAdV-C5, IC-HAdV and IVIg at 6 h (n = 3). D) Caspase 1 activation was measuredwith FAM-YVAD-FMK FLICA by flow cytometry.
MoDCwere preincubated with YVAD-FLICA for 1 h and exposed to LPS, LPS/nigericin, IVIg HAdV-C5 and IC-HAdV for 3 h. Nigericin
was added to MoDC at 2 h. This assay was performed in 3 donors with similar results E) GSDMDcleavage in IC-HAdV-challenged
MoDC in presence of caspase inhibitorswas monitoredby western blot. MoDCwere preincubated for 1 h with 20 or 100 μMZ-VAD,
YVAD, WEHD or an equal volume of DMSO followed by exposure to LPS/nigericin (added at 4 h), IVIg, HAdV-C5 and IC-HAdV for 6 h.
This assay was performed in 3 donors with similar results. F) GSDMDcleavage in IC-HAdV-challengedMoDC in presence of AIM2
inhibitors was monitoredby immunoblotting. MoDCwere pre-incubated for 2 h with 100 μMODNA151 followed by exposure to IVIg,
HAdV-C5 and IC-HAdV for 6 h This assay was performed in 3 donors with similar results.
doi:10.1371/journal.ppat.1005871.g007
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and microbial compounds they differentiate into macrophages or DCs, and then initiate anti-
microbial activity or promote T-cell responses. These characteristicsmake MoDCs a powerful
and clinically relevant ex vivo system to address the effect of human pathogens. An advantage
when using primary cultures of monocytes is the real-life variations associated with donors,
while a challenge is the generation of mutant cells that are defective in a specific pathway–with-
out perturbing their capacity to be influenced by the stimuli. We addressed these challenges by
repeating the assays in cells frommultiple donors and by using lentivirus vector shRNA-medi-
ated knockdown in freshly isolated monocytes prior to differentiation, respectively.
Previous studies addressing HAdV vector infection of THP-1 cells and murine macrophages
reported the activation of the NLRP3 inflammasome [28,30,78]. Barlan et al. reported that
HAdV-C5 can prime THP-1 cells for expression of pro-IL-1β and NLRP3 via TLR9 signaling.
HAdV-C5 also induces the NLRP3 inflammasome in both PAM3CSK4-primed and unprimed
THP-1 cells [78]. Notably, NLRP3mRNA levels are downregulated during the differentiation
frommonocytes into MoDC, whileAIM2mRNA levels are not affected. In addition, IC-HAdV
challenge increasedAIM2mRNA, but not NLRP3mRNA levels in MoDC. In spite of the pre-
vailing dogma that HAdV-C5 is highly immunogenic, we routinely find that compared to
Fig 8. IC-HAdV traffickingand cellular events leading to pyroptotic dendritic cell death. IC-HAdV are taken up via FcγR-mediated endocytosis
and fuse with TLR9+ endolysosomal vesicles because of NAb-dependent capsid stabilization at endosomal pH. At the more acidic pH in lysosome-like
vesicles, IC-HAdV begin to disassemble and to release viral DNA, membrane lytic protein VI, and cellular components. TLR9 engagement induces
MyD88-NF-κB-dependent de novo expression of TNF and pro-IL1β. During vesicular DNA sensing, protein VI release from the capsid leads to
endolysosomal membrane lysis and IC-HAdV gain access to the cytosol. The cytosolic inflammasome sensor AIM2 interacts with the HAdV-C5
genome and induces inflammasome assembly and activation of caspase 1, and downstream cleavage of pro-IL-1βand GSDMD. Together this leads to
pyroptosis of MoDCs.
doi:10.1371/journal.ppat.1005871.g008
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murine cells and human cell lines, HAdV-C5 internalization poorly induces human DCmatu-
ration [36]. Of note though, transfection of HAdV-C5 DNA into primary cultures of human
keratinocytes induces an NLRP3 response [89]. Yet, our data argue against the involvement of
NLRP3 in MoDCs challenged with IC-HAdVs. A significant difference in the induction of the
NLRP3 and AIM2 inflammasome is NLRP3’s requirement for priming [90–93]. Canonically,
NLRP3 activation is a two-step mechanism: initial activation includes the de novo expression
of inflammasome components (including NLRP3), and a second stimulus triggers inflamma-
some assembly [91]. A fundamentally different complex is assembled by AIM2, because
NLRP3 can self-oligomerize.AIM2 binds dsDNA at regular intervals in a length-dependent
manner. The relatively long linker between the HIN and the pyrin domain would then allow
the PYDs from several AIM2molecules to swing around the DNA core and oligomerize,
thereby nucleating ASC polymerization. The linear, 36-kb long HAdV genome likely makes it
an ideal AIM2 target and, importantly, aggregated HAdV genomes can be easily detected in
the cytoplasm of IC-HAdV-challenged MoDCs (S4D Fig).
Intuitively, there would appear to be a selective advantage for a host to be able to use AIM2
and NLRP3 in concert to fight pathogens [25,94]. In HeLa cells transfected with plasmids to
overexpress TRIM21, this intracellular FcR detects IC-HAdV and to target them for protea-
some degradation [95,96]. Because IC-HAdV access the cytosol in MoDC, it would have been
interesting to determine if this degradation pathway for cytosolic immune complexes is physio-
logically relevant in bona fide human APCs. However, TRIM21 knockdown in MoDCs was
inefficient in our hands.
Pyroptosis: pro-virusor pro-host?
Whether IC-HAdV-induced pyroptosis in other FcγR+ cells (e.g. neutrophils) occurs in a host
with HAdV NAbs during local or systemic injection of HAdV vectors is unknown. Intrigu-
ingly, neutropenia has been repeatedly associated with HAdV infections [97,98] and with
HAdV vector injections [99]. Like for HAdV-C5, humoral immunity increases inflammasome
induction for Staphylococcus aureus compared to the non-opsonized pathogen [100]. But, pyr-
optotic cells death is not a universal response to ICs: ICs containing ovalbumin, sheep red
blood cells, or Candida albicans block activation and assembly of AIM2, NLRP3 or NLRC4
inflammasomes via ligation of activating FcγRs [101]. How ICs affect inflammasome induction
likely depends on the size and topography of the complexes, the number of IgGs in the com-
plex, its ability to cluster and signaling through the FcγRs, and the ability of the antigen/patho-
gen to influence its processing.Most experiments that quantify pathogen burden in the
presence and absence of pro-inflammatory caspase-dependent immune responses suggest a
protective effect. However, disease progression is neither linear, nor identical, in all environ-
ments. Some pathogens may benefit from the activation of pro-inflammatory response during
specific stages of infection–in particular those that infect immune cells that are recruited to the
site of inflammation. HIV-1 is an interesting example; it infects activated CD4+ T cells that are
recruited to the site of infections, which results in an IFNγ-inducible protein 16-mediated pyr-
optosis of the bystander T cells [102].
For IC-HAdVs, opposing arguments for whether pyroptotic DC death is pro-virus or pro-
host could be made. Because TLR engagement increases phagosomematuration, lysosomal
acidification, and antigen degradation in murine DCs [103] rapid escape from an environment
that promotes antigen presentation may preclude efficientmemory T-cell stimulation and be
pro-HAdV. Destroying DCs by pyroptosis would be an efficientmean to prevent the stimula-
tion of memory T cells. However, pyroptosis is not an immunologically sterile response and
should stimulate the infiltration of immune cells into the site of infection that should eventually
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lead to pathogen control. In a healthy host, recurrent HAdV infections are readily controlled,
which suggests that this phenomenon should be, in most cases, pro-host. Yet, the equilibrium
between IC-HAdV formation, MoDCmaturation, T-cell activation, and pyroptotic DC death
may depend on the dynamic HAdV load during the course of a de novo infection or immune
escape. Indeed, we show that increased capsid stability is associated with greater TNF secretion.
IC-induced pyroptosis of FcγR+ cells may becomewidespread during HAdV-disseminated dis-
ease in T-cell deficient hematopoietic stem cell transplant patients. In this regard, IC-HAdV
likely form during HAdV infection because type-specificAbs are present in patients [6] and
thus, may contribute to the adverse effects like inflammation and trigger or worsen graft-versus
host disease [10–12,104]. Of note, inflammasomes can be ejected from cells, ingested by
bystander cells, and amplify a proinflammatory response [105,106].Whether this phenomenon
plays a role in the IL-1β levels in the supernatant, even after blocking the majority of AIM2
inflammasomeswith ODN A151, needs focused attention. Intriguingly, mucosal homing Th17
anti-HAdV T cells may be involved in acquisition of HIV infection following HAdV-based
vaccination [37–39]. IL-17 secretion correlated with HAdV-C5 pre-existing immunity when
PBMC from vaccinees in the STEP trial where re-stimulated with HAdV-C5 [107]. This
implies that upstream of the Th17 T-cell differentiation IL-1β plays a role that may be linked to
IC-HAdV-mediated pyroptosis.
In summary, our study provides a mechanistic understanding of how pre-existing humoral
immunity to HAdVs impact innate immunity via PRR in bona fide human APCs. Understand-
ing of the complex interplay betweenHAdV, NAbs, and innate sensor in human APCs may
enable us to develop therapies to treat disseminatedHAdV-disease, optimize AdV-based vac-
cines, and improve AdV-mediated gene transfer.
Supporting Information
S1 Table. Sequences or references (Open BioSystems) of the shRNAs used to knockdown
the production of the indicated proteins.
(DOCX)
S1 Fig. IgG-opsonization of HAdV-C5 increases binding and internalization into MoDC.
Internalization of HAdV-C5 ± IVIg was assessed by RT-qPCR the transgene and GAPDH in
DNA extracts from the indicated times. For each time point, total versus intracellular virus has
been distinguished by acid wash which partially removed extracellular capsid These assays
were performed in triplicate with more than 3 donors with similar results.
(TIF)
S2 Fig. IC-HAdV made using IVIg induce DCmaturation.MoDCs were incubated with
HAdV-C5, IC-HAdV, IVIg or LPS for 6 h. Flow cytometry profile of A) CD40 and B) CD86 in
MoDCs treated with the different stimuli compared to mock-treated cells (grey). C) MoDC
were exposed to HAdV-C5, IVIg and IC-HAdV for 30 min. Cell morphologywas assayed by
flow cytometry.
(TIF)
S3 Fig. IC-HAdV do not induce the NLRP3 inflammasome. Involvement of NLRP3 in
IC-HAdV-challenged was assessed by PI/flow cytometry. MoDCwere preincubated with
NLRP3-inhibitors KCl (20 and 40 mM) and 10 μMMCC950 for 1 h. or A) mock-treated or
exposed to LPS/nigericin and B) 20 and 40 mMKCl C) 10 μMMCC950. These experiments
were carried out in at least 2 individual donors with similar results.
(TIF)
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S4 Fig. Expression levels of inflammasomesensors.RT-qPCR analysis of A) AIM2 B) and
NLRP3mRNA levels in monocytes and MoDCs and after challenge with LPS or IC-HAdV in
MoDC. These assays were performed in triplicate using 3 donors with similar results. C)
Immunoblotting demonstrating lentivirus-mediated shRNA knockdown of AIM2 in MoDC.
D) Viral DNA is readily detected in the cells and remains associated with viral capsid in
IC-HAdV-challenged MoDC.MoDCwere exposed to IC-HAdV-488 for 3 h and prepared for
fluorescencemicroscopy with DAPI as counterstaining.
(TIF)
S5 Fig. PlasmidDNA induces loss of membrane integrity. MoDCs were pre-incubated with
10, 50 or 100 μMODN A151 for 2 h and transfectedwith plasmid DNA complexed by Lipofec-
tamine LTX and cell membrane integrity was assessed by PI/flow cytometry (n = 2).
(TIF)
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